These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 16859130)
21. Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1. Briggs CJ; Ott DE; Coren LV; Oroszlan S; Tözsér J Arch Virol; 1999; 144(11):2151-60. PubMed ID: 10603169 [TBL] [Abstract][Full Text] [Related]
23. In vitro cytokine responses in liver transplant recipients treated with cyclosporine A and tacrolimus. Golling M; Sadeghi M; Zipperle S; Fonouni H; Golriz M; Mehrabi A Clin Transplant; 2009 Dec; 23 Suppl 21():83-91. PubMed ID: 19930321 [TBL] [Abstract][Full Text] [Related]
24. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. Keicho N; Kudoh S; Yotsumoto H; Akagawa KS J Antibiot (Tokyo); 1993 Sep; 46(9):1406-13. PubMed ID: 7693639 [TBL] [Abstract][Full Text] [Related]
25. Effect of cyclosporin and tacrolimus (FK506) on the antigen-induced mediator release, membrane potential and 86Rb+/K+ and Ca2+ fluxes in the RBL-2H3 cell line. Narenjkar J; Assem el-SK; Wan BY; Marsh S; Ezeamuzie CI Int Immunopharmacol; 2006 May; 6(5):742-9. PubMed ID: 16546704 [TBL] [Abstract][Full Text] [Related]
26. Cyclosporine A inhibits interleukin-8 production in a human colon epithelial cell line (HT-29). Saitoh O; Matsuse R; Sugi K; Nakagawa K; Uchida K; Maemura K; Kojima K; Hirata I; Katsu K J Gastroenterol; 1997 Oct; 32(5):605-10. PubMed ID: 9349985 [TBL] [Abstract][Full Text] [Related]
27. Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures. Igarashi K; Hirotani H; Woo JT; Stern PH Bone; 2004 Jul; 35(1):47-56. PubMed ID: 15207740 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells. Hauser IA; Koziolek M; Hopfer U; Thévenod F Kidney Int; 1998 Oct; 54(4):1139-49. PubMed ID: 9767529 [TBL] [Abstract][Full Text] [Related]
29. FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes. Kaibori M; Inoue T; Tu W; Oda M; Kwon AH; Kamiyama Y; Okumura T Life Sci; 2001 May; 69(1):17-26. PubMed ID: 11411802 [TBL] [Abstract][Full Text] [Related]
30. Distinct patterns of cytokine gene suppression by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts. Jiang H; Yang X; Soriano RN; Fujimura T; Krishnan K; Kobayashi M Immunobiology; 2000 Sep; 202(3):280-92. PubMed ID: 11045663 [TBL] [Abstract][Full Text] [Related]
31. Regulation of liver regeneration by interleukin-2 and its inhibitors: cyclosporine A and FK 506. Tanaka N; Yamamoto H; Tatemoto A; Urabe T; Orita K Int J Immunopharmacol; 1993 Feb; 15(2):211-8. PubMed ID: 7682200 [TBL] [Abstract][Full Text] [Related]
32. Cyclosporine or FK506 decrease mature epidermal growth factor protein expression and renal tubular regeneration in rat kidneys with ischemia/reperfusion injury. Yang CW; Lee SH; Lim SW; Jung JY; Kim WY; Kim HW; Choi BS; Li C; Cha JH; Kim YS; Kim J; Bang BK Nephron; 2002 Dec; 92(4):914-21. PubMed ID: 12399639 [TBL] [Abstract][Full Text] [Related]
33. FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0/G1 phases of the cell cycle. Karashima T; Hachisuka H; Sasai Y J Dermatol Sci; 1996 Sep; 12(3):246-54. PubMed ID: 8884530 [TBL] [Abstract][Full Text] [Related]
34. Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells. Murakami R; Kambe F; Mitsuyama H; Okumura K; Murohara T; Niwata S; Yamamoto R; Seo H Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2034-40. PubMed ID: 12958044 [TBL] [Abstract][Full Text] [Related]
35. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis. Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519 [TBL] [Abstract][Full Text] [Related]
36. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Deppe CE; Heering PJ; Viengchareun S; Grabensee B; Farman N; Lombès M Endocrinology; 2002 May; 143(5):1932-41. PubMed ID: 11956176 [TBL] [Abstract][Full Text] [Related]
37. [Experimental studies on the mode of action of cyclosporine and FK506 assessed by proliferation response of human cloned T lymphocytes]. Matsuura T; Negita M; Ikegami M; Imanishi M; Nishioka T; Ishii T; Uemura T; Kunikata S; Kanda H; Akiyama T Hinyokika Kiyo; 1991 Oct; 37(10):1141-5. PubMed ID: 1721767 [TBL] [Abstract][Full Text] [Related]
38. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1. Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327 [TBL] [Abstract][Full Text] [Related]
39. Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. Du S; Hiramatsu N; Hayakawa K; Kasai A; Okamura M; Huang T; Yao J; Takeda M; Araki I; Sawada N; Paton AW; Paton JC; Kitamura M J Immunol; 2009 Jun; 182(11):7201-11. PubMed ID: 19454717 [TBL] [Abstract][Full Text] [Related]
40. Cyclosporin A and FK-506 in inhibition of rat Ito cell activation in vitro. Ikeda H; Fujiwara K Hepatology; 1995 Apr; 21(4):1161-6. PubMed ID: 7535735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]